Wikidata entity: Q425681
C₁₃H₁₃N₃O₃ (P274)
Quantities
| P4250 | defined daily dose | 10 |
| P2067 | mass | 259.095691 |
| P3780 | active ingredient in | ... | Q29006434 (Revlimid) | Revlimid |
| P233 | canonical SMILES | String | C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N | ??? |
| P373 | Commons category | String | Lenalidomide | ??? |
| P31 | instance of | ... | Q59199015 (group of stereoisomers) | group of stereoisomers |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P2175 | medical condition treated | ... | Q29496 (leukemia) | leukemia |
| P2175 | medical condition treated | ... | Q136312 (central nervous system lymphoma) | central nervous system lymphoma |
| P2175 | medical condition treated | ... | Q208414 (lymphoma) | lymphoma |
| P2175 | medical condition treated | ... | Q816798 (amyloidosis) | amyloidosis |
| P2175 | medical condition treated | ... | Q5445 (anemia) | anemia |
| P2175 | medical condition treated | ... | Q954625 (myelodysplastic syndrome) | myelodysplastic syndrome |
| P2175 | medical condition treated | ... | Q245455 (chromosome 5q deletion syndrome) | chromosome 5q deletion syndrome |
| P2175 | medical condition treated | ... | Q264118 (acute myeloid leukemia) | acute myeloid leukemia |
| P2175 | medical condition treated | ... | Q268713 (mantle cell lymphoma) | mantle cell lymphoma |
| P2175 | medical condition treated | ... | Q467635 (multiple myeloma) | multiple myeloma |
| P2175 | medical condition treated | ... | Q1088072 (chronic myelomonocytic leukemia) | chronic myelomonocytic leukemia |
| P2175 | medical condition treated | ... | Q1088156 (chronic lymphocytic leukemia) | chronic lymphocytic leukemia |
| P2175 | medical condition treated | ... | Q1138590 (non-Hodgkin lymphoma) | non-Hodgkin lymphoma |
| P2175 | medical condition treated | ... | Q1752571 (myelofibrosis) | myelofibrosis |
| P2175 | medical condition treated | ... | Q1778287 (Waldenström macroglobulinemia) | Waldenström macroglobulinemia |
| P2175 | medical condition treated | ... | Q1891209 (mycosis fungoides) | mycosis fungoides |
| P2175 | medical condition treated | ... | Q2090167 (plasmacytoma) | plasmacytoma |
| P2175 | medical condition treated | ... | Q55785650 (refractory anemia with excess blasts in transformation) | refractory anemia with excess blasts in transformation |
| P2175 | medical condition treated | ... | Q2626074 (diffuse large B-cell lymphoma) | diffuse large B-cell lymphoma |
| P2175 | medical condition treated | ... | Q4833719 (B-cell lymphoma) | B-cell lymphoma |
| P2175 | medical condition treated | ... | Q7201765 (plasma cell leukemia) | plasma cell leukemia |
| P2175 | medical condition treated | ... | Q7307574 (Refractory cytopenia with multilineage dysplasia) | Refractory cytopenia with multilineage dysplasia |
| P2175 | medical condition treated | ... | Q7667896 (T-cell lymphoma) | T-cell lymphoma |
| P2175 | medical condition treated | ... | Q18553445 (mature T-cell and NK-cell lymphoma) | mature T-cell and NK-cell lymphoma |
| P2175 | medical condition treated | ... | Q18553852 (lymphoblastic leukemia) | lymphoblastic leukemia |
| P3489 | pregnancy category | ... | Q3679561 (Australian pregnancy category X) | Australian pregnancy category X |
| P3489 | pregnancy category | ... | Q28123619 (US pregnancy category X) | US pregnancy category X |
| P279 | subclass of | ... | Q12140 (medication) | medication |
| P2868 | subject has role | ... | Q574834 (angiogenesis inhibitor) | angiogenesis inhibitor |
| P2868 | subject has role | ... | Q50349184 (immunologic factor) | immunologic factor |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | lenalidomide | ??? |
Why not click here or view trends?
log id: 2544038